RUA Life Sciences (FRA:AOHA) YoY EBITDA Growth : -22.00% (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. RUA Life Sciences's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was -22.00%.

RUA Life Sciences's EBITDA per Share for the six months ended in Sep. 2023 was €-0.06.

RUA Life Sciences YoY EBITDA Growth Historical Data

The historical data trend for RUA Life Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences YoY EBITDA Growth Chart

RUA Life Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

-194.74

-50.00

-57.41

-29.41

9.09

RUA Life Sciences Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial															-103.33	7.84	18.03	-8.51	-22.00

RUA Life Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

RUA Life Sciences's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(-0.1	-	-0.11)	/	\| -0.11 \|
=	9.09 %

RUA Life Sciences's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(-0.061	-	-0.05)	/	\| -0.05 \|
=	-22.00 %

RUA Life Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences (FRA:AOHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Scotland, Irvine, Ayrshire, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.

RUA Life Sciences (FRA:AOHA) Headlines

No Headlines